The effect of endocrine therapy on the levels of oestrogen and progesterone receptor and transforming growth factor-β1 in metastatic human breast cancer: an immunocytochemical study
- 31 December 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (9) , 1218-1222
- https://doi.org/10.1016/0959-8049(94)90161-9
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The prognostic significance of transforming growth factors in human breast cancerBritish Journal of Cancer, 1993
- Does the oestrogen receptor concentration of a breast cancer change during systemic therapy?British Journal of Cancer, 1990
- Transcripts for transforming growth factors in human breast cancer: clinical correlatesBritish Journal of Cancer, 1990
- Approaches to studying the role of growth factors in the progression of breast tumours from the steroid sensitive to insensitive stateJournal of Steroid Biochemistry, 1989
- Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell linesThe Journal of Steroid Biochemistry and Molecular Biology, 1989
- Estrogen induced increase of estrogen receptor RNA in human breast cancer cellsBiochemical and Biophysical Research Communications, 1988
- Induction of progesterone receptor with tamoxifen in human breast cancer with special reference to its behavior over timeCancer, 1988
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987
- Effects of endocrine therapy on steroid-receptor content of breast cancerBritish Journal of Cancer, 1982
- Changes in multiple or sequential estrogen receptor determinations in breast cancerCancer, 1980